Guangdong Zhongsheng

Guangdong Zhongsheng is a company listed under the stock ticker 002317 (CN).

View the org chart displaying its 11 main executives

Most searched biographies at Guangdong Zhongsheng

• Yong Hong Chen, Chairman of the Board, General Manager
• Peng'an Shan, Director
• Xiaorong Mou, Independent Director

Create your alert
to follow the executive moves at Guangdong Zhongsheng.

Guangdong Zhongsheng has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Guangdong Zhongsheng

Social media about Guangdong Zhongsheng

• Guangdong Zhongsheng on Wikipedia, Google News & Yahoo Finance
• Guangdong Zhongsheng on LinkedIn, Twitter & YouTube

Call Guangdong Zhongsheng at +86 769 ...

View the org chart

Register to receive your alert

Report an error